Liang Cui

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Molecularly Imprinted

Combination Therapy

Tyrosine Kinase

Top Venues

British journal of cancer

Cell death & disease

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Gehan Xu, Liang Cui, Jin Li, Quanren Wang, Pansong Li, Xuefeng Xia, Xin Yi, Quanlin Guan, Jian-Ming Xu
bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy. Clinical and translational medicine 12 (10) (2022)
Xinyu Zhang, Zhuo Yu, Yaping Xu, Yencheng Chao, Qin Hu, Chun Li, Maosong Ye, Xiuli Zhu, Liang Cui, Jing Bai, Yuhua Gong, Yanfang Guan, Min Zhou, Jian'an Huang, Hua Zhang, Tao Ren, Qian Shen, Kai Wang, Yingyong Hou, Xuefeng Xia, Xingxiang Pu, David P Carbone, Xin Zhang
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodules. British journal of cancer 127 (12) (2022)
Zhiyong Deng, Liang Cui, Pansong Li, Nianjun Ren, Zhe Zhong, Zhi Tang, Lei Wang, Jianwu Gong, Haofeng Cheng, Yanfang Guan, Xin Yi, Xuefeng Xia, Rongrong Zhou, Zhengwen He
Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma. Cell death & disease 12 (10) (2021)